Feed GMED
GM

Globus Medical GMED · NYSE

$76.69 -2.73% (-$2.15)

Market cap
$10.6B
Enterprise value
$10.2B
P/E
19.8x
Forward P/E
15.4x
PEG
0.0x
P/S
3.4x
P/FCF
14.1x
EV/EBITDA
11.6x
ROIC
10.5%
Gross margin
68.5%
Net margin
17.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-0.5x
Beta
0.96
Free float
99.3%

About the company

Globus Medical, Inc. (GMED) is an American company specializing in the development, manufacturing, and distribution of orthopedic implants and surgical devices. With a wide portfolio of innovative products, Globus Medical is known for its efforts to improve treatment options for patients with spine conditions and injuries. The company focuses on providing high-quality and reliable products that help surgeons achieve optimal outcomes in surgical procedures. Globus Medical also invests in research and development of new technologies and products that enhance the lives of patients with musculoskeletal disorders. Globus Medical, Inc. (GMED) shares could be suitable for investors looking to invest in the healthcare sector with an emphasis on orthopedic implants and surgical devices.

Sector

Healthcare

Industry

Medical - Devices

CEO

Keith W. Pfeil

Employees

6,000

Headquarters

Audubon

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.